Massachusetts Still Has No DPC Law. The Bill That Would Remove a Major Practice Barrier Is Down to One Chamber.

Legislation by DPC Insider
#Massachusetts#state legislation#physician dispensing#specialist referrals#primary care#DPC law
Sources: Testimony in Support of H.1160/S.2732, An Act Relative to Direct Primary Care (2026) · Massachusetts — Direct Primary Care Frontier · Senators Eye Penalties to Enforce Primary Care Investment

In most states, a DPC physician can hand a patient a bottle of metformin on the way out the door. In Massachusetts, that’s not something the law makes straightforward.

Massachusetts restricts physician in-office dispensing to sample medications and to single doses for immediate need. Samples are capped at a 30-day supply, or 90 days through a manufacturer’s indigent drug program. The kind of wholesale medication dispensing that DPC practices in Oklahoma and Kansas do as a matter of routine has no clear legal home in Massachusetts. Physicians there operate without the statutory protections that most of their counterparts elsewhere take for granted.

A bill in the Massachusetts House would change this. H.5022 — the redraft of H.1343 that the Joint Committee on Financial Services reported out on February 5, 2026 — is named for direct primary care, but what it changes is narrower than that: the dispensing statute, and whether a carrier can refuse to pay for care on the grounds that the referral came from an out-of-network provider. The Senate companion, S.2732, is not moving alongside it: the Senate sent that version to a study order on February 26, 2026, which in Massachusetts is how a bill gets shelved for the session. The Massachusetts Medical Society testified in support on January 13, 2026. Dr. Wayne Altman, professor and chair of family medicine at Tufts School of Medicine, has said he hopes lawmakers will enact “Primary Care for You” by summer 2026 — that is S.3116, the Senate’s broader primary care bill, not this one.

What the Bill Would Actually Do

Two things stand out in H.5022.

The first is the dispensing piece. If it passes, Massachusetts DPC physicians could dispense medications directly from their offices. That’s a meaningful operational change. DPC practices that can dispense generic medications at wholesale prices can offer patients blood pressure drugs, diabetes medications, and antibiotics for a few dollars a month, often included in the membership. Without that ability, Massachusetts DPC physicians have to send patients to a retail pharmacy, which cuts off one of the most visible cost advantages of the model.

Physician dispensing rules vary by state. DPC Frontier maintains a state-by-state guide for physicians verifying their own state’s requirements.

The second piece is the specialist referral fix, and it may matter just as much.

Most DPC practices don’t contract with insurance companies. When a DPC physician writes a referral to a specialist, the patient’s insurer sometimes rejects it or declines coverage because the referring physician isn’t in their network. Massachusetts law doesn’t require insurers to recognize out-of-network referrals in this situation. H.5022 would change that. Under the bill, insurers would have to cover specialist visits when a DPC physician refers the patient, even if that physician has no insurance contract.

This doesn’t force insurers to pay for the DPC membership itself. But it closes a gap that makes Massachusetts DPC membership feel incomplete for anyone who has insurance and needs anything beyond routine primary care. Patients who join a DPC practice expecting full access to care can hit a wall the moment they need a cardiologist or an orthopedist.

The Massachusetts DPC Frontier page notes that a Massachusetts DPC Coalition, led by practicing physicians Jeff Gold and Rushika Fernandopulle, has been laying the groundwork for this legislation. The state’s insurance commissioner has also issued guidance clarifying how DPC agreements can be structured to avoid triggering insurance regulations, but guidance letters aren’t law. H.5022 would not change that. Its sections amend the dispensing statute and bar carriers from denying payment on an out-of-network referral; none of them address DPC agreements or insurance regulation. The commissioner’s guidance stays guidance.

Where the State Stands

Massachusetts has a documented primary care shortage. The Senate Ways and Means Committee reported a separate piece of legislation, S 3116, to the Senate floor on June 11. It takes a more traditional approach to the problem: requiring carriers and the Group Insurance Commission to meet phased primary care spending targets of 9% of total health care expenditures in 2028, 12% in 2029, and 15% in 2030. Healthcare entities that miss the targets and don’t improve would face financial penalties. The Health Policy Commission would gain enforcement authority.

S 3116 doesn’t mention DPC. But the two bills together describe a state that has run out of patience with its primary care access problem and is willing to try more than one thing at once. One bill pushes more money into the existing insurance-based system. The other clears space for a model that routes around it.

Whether both approaches can coexist in the same state without creating coverage gaps or administrative friction is a question the legislation doesn’t fully resolve. That’s a debate worth watching if both advance.

What This Means

For physicians practicing in Massachusetts, or considering starting a DPC practice there, H.5022 is worth following through the remainder of the legislative session. If it passes, Massachusetts would join the majority of states that have formal DPC protections on the books. The dispensing change specifically would give Massachusetts DPC physicians a capability that changes the economics and convenience of the model for patients.

For residents in Massachusetts training programs who are weighing DPC as a path after residency, the current legal landscape is one of the factors that makes Massachusetts a harder state to launch in than, say, Oklahoma or Texas. H.5022 passing would narrow that gap.

For DPC physicians elsewhere, the Massachusetts story is a data point about how state-level DPC legislation is evolving. MMS support for a DPC bill is not something that would have happened automatically a few years ago. That a major state medical society is publicly backing DPC protections in one of the country’s most insurance-regulated states says something about where the profession’s center of gravity is moving.

The bill still has to get out of the Health Care Financing Committee, pass both chambers, and reach the governor’s desk — and with the Senate’s own version in study, that means the Senate taking up the House bill rather than moving its companion. That’s a real legislative gauntlet in Massachusetts. But the conversation has shifted in a direction that would have seemed unlikely not long ago.